Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid cancer, Hurthle cell × dabrafenib × 90 days × Clear all

Sponsor

Conditions

Melanoma 7 Glioma 5 Multiple Myeloma 4 Carcinoma, Non-Small-Cell Lung 3 Thyroid Carcinoma, Anaplastic 2 Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hematologic Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Astrocytoma 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Laryngeal Neoplasms 1

Interventions

gallium Ga 68 dotatate 1 Sorafenib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡